Endothelium-derived hyperpolarizing factor contributes to hypoxia-induced skeletal muscle vasodilation in humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 11, 2013, Pages

  Spilk, Samson ^a   Herr, Michael D ^a   Sinoway, Lawrence I ^a   Leuenberger, Urs A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Endothelium derived hyperpolarizing factor; Fluconazole; Hypoxia; Nitric oxide; Vasodilation

Indexed keywords

ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FLUCONAZOLE; N(G) METHYLARGININE;

ADULT; ARTICLE; BLOOD VESSEL TONE; BRACHIAL ARTERY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; HYPOXIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SKIN BLOOD FLOW; VASODILATATION;

ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR; FLUCONAZOLE; HYPOXIA; NITRIC OXIDE; VASODILATION;

ADULT; ANOXIA; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL FACTORS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FLUCONAZOLE; FOREARM; HEART RATE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PULMONARY VENTILATION; REGIONAL BLOOD FLOW; VASODILATION;

EID: 84888859532     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00073.2013     Document Type: Article

References (36)

1. Ca channels. Circulation 107: 769-776, 2003.
2. Baylie RL, Brayden JE. TRPV channels and vascular function. Acta Physiol (Oxf) 203: 99-116, 2011.
3. Bellien J, Iacob M, Gutierrez L, Isabelle M, Lahary A, Thuillez C, Joannides R. Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation. Hypertension 48: 1088-1094, 2006.
4. Bellien J, Joannides R, Iacob M, Arnaud P, Thuillez C. Calciumactivated potassium channels and NO regulate human peripheral conduit artery mechanics. Hypertension 46: 210-216, 2005.
5. Bellien J, Joannides R, Iacob M, Arnaud P, Thuillez C. Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans. Am J Physiol Heart Circ Physiol 290: H1347-H1352, 2006.
6. Blauw GJ, Westendorp RG, Simons M, Chang PC, Frolich M, Meinders AE.-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man. Br J Clin Pharmacol 40: 453-458, 1995.
7. Blitzer ML, Lee SD, Creager MA. Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humans. Am J Physiol Heart Circ Physiol 271: H1182-H1185, 1996.
8. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97: 9747-9752, 2000.
9. Casey DP, Madery BD, Curry TB, Eisenach JH, Wilkins BW, Joyner MJ. Nitric oxide contributes to the augmented vasodilatation during hypoxic exercise. J Physiol 588: 373-385, 2010.
10. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505, 2003.
11. Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res 49: 525-533, 2004.
12. Fleming I, Busse R. Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 47: 629-633, 2006.
13. Hillig T, Krustrup P, Fleming I, Osada T, Saltin B, Hellsten Y. Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans. J Physiol 546: 307-314, 2003.
14. Leuenberger U, Gleeson K, Wroblewski K, Prophet S, Zelis R, Zwillich C, Sinoway L. Norepinephrine clearance is increased during acute hypoxemia in humans. Am J Physiol Heart Circ Physiol 261: H1659-H1664, 1991.
15. Leuenberger UA, Gray K, Herr MD. Adenosine contributes to hypoxiainduced forearm vasodilation in humans. J Appl Physiol 87: 2218-2224, 1999.
16. Leuenberger UA, Johnson D, Loomis J, Gray KS, Maclean DA. Venous but not skeletal muscle interstitial nitric oxide is increased during hypobaric hypoxia. Eur J Appl Physiol 102: 457-461, 2008.
17. Luksha L, Agewall S, Kublickiene K. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 202: 330-344, 2009.
18. MacLean DA, Sinoway LI, Leuenberger U. Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation 98: 1990-1992, 1998.
19. Markwald RR, Kirby BS, Crecelius AR, Carlson RE, Voyles WF, Dinenno FA. Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans. J Physiol 589: 1979-1990, 2011.
20. Marshall JM. The integrated response to hypoxia: from circulation to cells. Exp Physiol 84: 449-470, 1999.
21. Marshall JM. The roles of adenosine and related substances in exercise hyperaemia. J Physiol 583: 835-845, 2007.
22. Messina EJ, Sun D, Koller A, Wolin MS, Kaley G. Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle. Circ Res 71: 790-796, 1992.
23. Moradkhan R, McQuillan P, Hogeman C, Leuenberger A, Linton-Frazier L, Leuenberger UA. Metabolic forearm vasodilation is enhanced following Bier block with phentolamine. Am J Physiol Heart Circ Physiol 293: H2289-H2295, 2007.
24. Neylon M, Marshall JM. The role of adenosine in the respiratory and cardiovascular response to systemic hypoxia in the rat. J Physiol 440: 529-545, 1991.
25. Ozkor MA, Murrow JR, Rahman AM, Kavtaradze N, Lin J, Manatunga A, Quyyumi AA. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation 123: 2244-2253, 2011.
26. Ray CJ, Abbas MR, Coney AM, Marshall JM. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol 544: 195-209, 2002.
27. Richardson DW, Kontos HA, Raper AJ, Patterson JL Jr. Modification by-adrenergic blockade of the circulatory responses to acute hypoxia in man. J Clin Invest 46: 77-85, 1967.
28. Roddie IC, Wallace WF. Methods for the assessment of the effects of drugs on the arterial system in man. Br J Clin Pharmacol 7: 317-323, 1979.
29. Rowell LB. Circulatory adjustments to dynamic exercise. In: Human Circulation Regulation During Physical Stress, edited by Rowell LB. New York: Oxford University Press, 1986, chapt. 9, p. 220.
30. Rowell LB, Johnson DG, Chase PB, Comess KA, Seals DR. Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol 66: 1736-1743, 1989.
31. Saito M, Mano T, Iwase S, Koga K, Abe H, Yamazaki Y. Responses in muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol 65: 1548-1552, 1988.
32. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 111: 796-803, 2005.
33. Simmons GH, Minson CT, Cracowski JL, Halliwill JR. Systemic hypoxia causes cutaneous vasodilation in healthy humans. J Appl Physiol 103: 608-615, 2007.
34. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, Magagna A, Virdis A, Salvetti A. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 48: 508-515, 2006.
35. Weisbrod CJ, Minson CT, Joyner MJ, Halliwill JR. Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol 537: 613-621, 2001.
36. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138: 103-141, 2013.